SCHEMBL8034618

SCHEMBL8034618

CCOC(=O)CN1CCC(=O)C(CC(=O)OCC)(C(=O)OC)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ELANE P08246 1/20 0.37
ALOX15 P16050 1/20 0.36
GSK3A P49840 2/20 0.35
GSK3B P49841 2/20 0.35
CYP2D6 P10635 1/20 0.34
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
PIN1 Q13526 1/20 0.33
PIN4 Q9Y237 1/20 0.33
CACNA1C Q13936 1/20 0.32
OPRM1 P35372 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29268477 0.76 KMT2A (0.43) KMT2AL3MBTL1ELANEALOX15GSK3A
SCHEMBL22722152 0.76 CHRM5 (0.39) L3MBTL1ALDH1A1CACNA1COPRM1
SCHEMBL11307926 0.75 GAA (0.48) KMT2AL3MBTL1CYP2D6LMNAALDH1A1
SCHEMBL7797419 0.70 GSK3B (0.49) KMT2AELANEALOX15GSK3AGSK3B
SCHEMBL23727469 0.67 MGAM (0.38) KMT2AELANEALOX15GSK3AGSK3B
SCHEMBL13389814 0.67 KDM4E (0.36) L3MBTL1CACNA1COPRM1
SCHEMBL1918461 0.67 CYP2C19 (0.40) KMT2AL3MBTL1ELANEALOX15CYP2D6
SCHEMBL21465773 0.67 CYP2D6 (0.46) KMT2AL3MBTL1CYP2D6ALDH1A1GAA
SCHEMBL23726999 0.66 ELANE (0.40) KMT2AL3MBTL1ELANEGSK3AGSK3B
SCHEMBL23727553 0.66 MGAM (0.37) KMT2AELANEGSK3AGSK3BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0793653-A1 CERTAIN 4-AMINOMETHYL-2-SUBSTITUTED IMIDAZOLE DERIVATIVES AND 2-AMINOMETHYL-4-SUBSTITUTED IMIDAZOLE DERIVATIVES; NEW CLASSES OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1997-09-10 EP claimed
WO-1996016040-A1 CERTAIN 4-AMINOMETHYL-2-SUBSTITUTED IMIDAZOLE DERIVATIVES AND 2-AMINOMETHYL-4-SUBSTITUTED IMIDAZOLE DERIVATIVES; NEW CLASSES OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1996-05-30 WO claimed
US-6057324-A HAVE GPIIB/IIIA RECEPTOR ANTAGONIZING ACTIVITY AND ARE USEFUL FOR AMELIORATING ISCHEMIC CARDIAC DISORDERS, FOR AMELIORATING CEREBROVASCULAR DISORDERS, AND FOR AMELIORATING PERIPHERAL ARTERY DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD (JP) 2000-05-02 US disclosed
EP-0905129-A1 SUBSTITUTED AMIDINOBENZENE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1999-03-31 EP disclosed
US-5773442-A EXHIBIT GPIIB/IIIA RECEPTOR ANTAGONISTIC ACTIVITY; USEFUL FOR THE TREATMENT AND PROPHYLAXIS OF VASCULAR SYSTEM DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1998-06-30 US disclosed
EP-0810215-A1 NOVEL BENZAMIDINE DERIVATIVES AND MEDICINAL COMPOSITION THEREOF YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1997-12-03 EP disclosed